Finnish-Dutch engineering cooperation continues

The University of Helsinki and ASM International renew a fice year research agreement on Atomic Layer Deposition.

Biotech goes white and bright

White biotech could become Denmark's next blossoming business area.

Infidelity produces faster sperms

Until now, it has been difficult to prove that fast-swimming sperms have an advantage when it comes to fertilizing an egg.

New NO product reduces diabetic pain

The Swedish medtech company Nolabs has announced that it has achieved an important milestone in the development of a new line of products.

Eli Lilly writes biotech fine history

The American biotech company Eli Lilly will pay US 1.415 billion to resolve allegations of off-label promotion of a dementia drug.

Positive combined cancer therapy

Topotarget announces positive data with new treatment against colorectal cancer.

Abbott expands by acquisition

An acquisition gives Abbott a leadership position in another large and growing medical device segment.

Swedish multi competent machine soon launched

The Swedish company Biosensor will launch new equipment able to detect twelve different narcotics and explosives simultaneously.

Measure blood sugar without finger pricking

The Danish entrepreneurial firm RSP Systems has developed a method to measure the blood sugar level in diabetes patients, simply by placing a fingertip on a small illuminating lens.

Polymer guru new dean at DTU

The Technical University of Denmark, DTU, has appointed a well-known profile from the Polymer Center as a new dean.

Finnish Innovation Fund gets new leader

The Supervisory Board of the Finnish Innovation Fund Sitra has appointed members of the Board, including a new president.

Schizophrenia and bipolar disorder are relatives

Schizophrenia and bipolar disorder have the same genetic causes, according to a study from Karolinska Institutet.

Crafoord Prize to an American and two Japanese

Today the Royal Swedish Academy of Sciences announces the laureates of the Crafoord Prize in Polyarthritis 2009.

LEO Pharma - International Clinical Trial Manager

New map of eye proteins

A new mapping of proteins in the eye opens the door for new treatments of eye diseases in the future.

Medicult disclaims Swedish offer

The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.

Ten recieve the Venture Cup West Prize

At this year´s Venture Cup West awards the 10 best business ideas in Venture Cup West 08/09 were chosen, receiving SEK 10 000 each.

Parnevik firm in Swiss osteoporosis deal

The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.

Norwegian entrance in EU technology network

The Norwegian University of Science and Technology joins the European Science Business Network of prominent European research institutions.

New CEO to Medivir

The Board of the Swedish biotech company Medivir has appointed the successor to the current CEO Lars Adlersson.

View pathology images in your iPhone

The Institute for Medical Informatics in Oslo announces a brand new iPhone application for virtual microscopy.

Vitrolife wants to acquire Medicult

The Swedish company Vitrolife intends to make en exchange offer to the shareholders of the Danish company Medicult to acquire all outstanding shares in the company.

Norwegian cancer therapy leaves phase II

New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.

Collaboration brings next generation drugs

Wyeth and Santaris Pharma announce a new alliance to develop RNA-based medicines.